MARGARET KELLY: Open Payments
NPI 1194378455 · WATERFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $238 |
| Lilly USA, LLC | 5 | $92 |
| Novo Nordisk Inc | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| Amgen Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, QULIPTA, Kerendia, MOUNJARO, Wegovy, OTEZLA, FARXIGA, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
